Ulf53, this ethics approval is a big deal, and the next step is government approval to proceed to a small group human trial. While Lexaria waits for the government approval, they are moving forward with an animal trial to prove there is no harm. It looks to me like they could have phase 1 clinical trial by late Winter or early Spring.

While this initial study is dealing with ability to use DehydraTech on drugs to treat Covid-19, it will also have broader implication for the entire pharmaceutical industry. And, a study involving Covid-19 will provide LXRP with a great deal of media attention.



Kgem